Patents by Inventor Shelley L. Lusetti

Shelley L. Lusetti has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7176007
    Abstract: The present invention provides RecA mutant proteins, having either a single mutation or a double mutation. The RecA mutant proteins are highly proficient in both SSB displacement and steady state binding of DNA in the presence or absence of SSB as compared to the wild-type protein. The single RecA mutant, RecA?C17, has 17 amino acid residues removed from the carboxyl terminus. The double mutant RecA, RecA?C17/E38K, combines the 17 amino acid residue C-terminal deletion of RecA?C17, with a single amino acid change from Glutamate to Lysine at position 38. These RecA mutant proteins are pH sensitive allowing control over formation of products. Hence, methods of using the novel RecA mutants and kits having the RecA mutants as components thereof are also contemplated by the present invention.
    Type: Grant
    Filed: December 11, 2003
    Date of Patent: February 13, 2007
    Assignee: Wisconsin Alumni Research Foundation
    Inventors: Michael M. Cox, Shelley L. Lusetti, Aimee L. Eggler, Nami Haruta
  • Publication number: 20040157248
    Abstract: The present invention provides RecA mutant proteins, having either a single mutation or a double mutation. The RecA mutant proteins are highly proficient in both SSB displacement and steady state binding of DNA in the presence or absence of SSB as compared to the wild-type protein. The single RecA mutant, RecA&Dgr;C 17, has 17 amino acid residues removed from the carboxyl terminus. The double mutant RecA, RecA&Dgr;C17/E38K, combines the 17 amino acid residue C-terminal deletion of RecA&Dgr;C17, with a single amino acid change from Glutamate to Lysine at position 38. These RecA mutant proteins are pH sensitive allowing control over formation of products. Hence, methods of using the novel RecA mutants and kits having the RecA mutants as components thereof are also contemplated by the present invention.
    Type: Application
    Filed: December 11, 2003
    Publication date: August 12, 2004
    Inventors: Michael M. Cox, Shelley L. Lusetti, Aimee L. Eggler, Nami Haruta